CBChristoph Becker

Christoph Becker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christoph Becker has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multidisciplinary Tumor Board in Oropharyngeal Cancer: Impact on Treatment Regimen, Treatment Initiation and Survival

    by V. Burkhardt, K. El-Shabrawi, A. Spörlein, T. Schulz, S. Riemann, C. Becker, C. Yildiz

  • Open Access

    Routine Histopreparations After Tonsillectomy, Tonsillotomy, Adenotomy or Conchotomy: A Necessary Diagnosis in Times of Dwindling Resources?

    by Givi Magradze, Felix Deffner, Manuel Christoph Ketterer, Christoph Becker, Andreas Knopf

    Objective: The primary objective of this study is to investigate the prevalence of unexpected findings requiring treatment after routine histological examinations following tonsillectomy, tonsillotomy, adenotomy, or conchotomy (TTAC) in a retrospective study and to discuss whether routine histological examination is useful in patients without clearly defined risk factors or whether it would be better to reduce unnecessary costs and resource utilisation. Materials and methods: The present retrospective study encompasses 5709 patients who underwent routine histological examinations following TTAC and were treated as inpatients at the University Medical Center Freiburg, Department of Otolaryngology, Head and Neck Surgery, between 2011 and 2021. The data was collected based on patient characteristics, including date of birth, gender, age of patients at the time of surgery, date of surgery, indication for surgery, tissue examined, and histological result. Results: Of a total of 6687 patients who underwent TTAC, 5709 with routine histological examinations were included in the analysis, of whom only four showed abnormal findings, corresponding to an overall prevalence of 0.07%. Three of these four patients were adults. These included two cases of granulomatous inflammation, one instance of Burkitt lymphoma, and one instance of chronic lymphocytic leukaemia/small cell B-lymphoma. Following the exclusion of tuberculosis and sarcoidosis, and the lymphoma board’s decision to adopt a watch-and-wait approach in the case of chronic lymphocytic leukaemia/small cell B-cell lymphoma, only n = 1/0.0175% of patients were found to require treatment. Conclusions: The study demonstrated that only four abnormal histological findings occurred in 5709 inpatient TTACs, of which only one, namely Burkitt lymphoma, ultimately required treatment. Consequently, it can be concluded that routine histological examinations following TTAC are not beneficial in patients without clearly defined risk factors, such as blood in the saliva, history of smoking or alcohol consumption, unexplained pain, previous cancer, mucosal changes, or tissue asymmetries. However, in instances where clinical or anamnestic suspicion of malignancy is present, a histological examination should be conducted.


  • Open Access

    Is hemithyroidectomy enough? Low risk of occult contralateral disease in sporadic medullary thyroid cancer

    by Andreas Spörlein, Christoph Becker, Joseph Berthelot, Valentin Burkhardt, Katharina Laubner, Mira Fink, Bernd Jänigen

    Purpose: Total thyroidectomy (TT) remains the standard surgical treatment of sporadic medullary thyroid cancer (sMTC), primarily due to the presumed risk of occult contralateral disease. However, recent evidence suggests that in selected patients, hemithyroidectomy (HT) may offer comparable oncologic outcomes. This retrospective study aimed to evaluate the prevalence of occult contralateral disease and to identify clinicopathological factors associated with disease-free survival (DFS). Methods: We retrospectively analyzed all surgical patients with sMTC at a tertiary academic center (2013–2025), excluding patients with hereditary MTC, RET mutations, or clinical evidence of MEN2. Kaplan-Meier analysis with logrank testing was used to identify predictors of DFS. Results: Forty-eight patients were included (66.7% female, median age 60.5 years). TT was performed in 44 patients (91.7%). Bilateral disease was present in five patients (11.4%), all detected on preoperative ultrasound. No cases of occult contralateral disease were found. During a median follow-up of 3.4 years, seven patients (14.6%) experienced recurrence. Advanced T stage, nodal involvement, distant metastases, lymphatic and vascular invasion, extracapsular extension, and male sex were all significantly associated with reduced DFS (all p < 0.05). Persistent postoperative calcitonin elevation (> 2 pg/mL) strongly predicted recurrence ( p < 0.001), whereas baseline calcitonin > 500 pg/mL did not. Conclusion: Occult contralateral disease in sMTC is rare when high-quality preoperative ultrasound is available. In selected patients with unifocal, node-negative tumors and favorable pathology, HT combined with structured calcitonin monitoring may be an oncologically safe, less morbid alternative. These findings support individualized, risk-adapted surgical strategies in sMTC. Prospective validation is warranted.


  • Open Access

    Impact of a Multidisciplinary Head and Neck Tumor Board on Treatment and Survival in Laryngeal Carcinoma

    by Katharina El-Shabrawi, Valentin Burkhardt, Christoph Becker

    Background: Pretherapeutic discussion in the head and neck tumor board (HNT) has been mandatory at the University Medical Center Freiburg since 01/2015, and it is intended to contribute to a survival benefit through interdisciplinary decision making. Prior to 2015, an optional HNT existed in which mainly advanced tumor stages were discussed. The aim of this study was to determine the effect of a pretherapeutic HNT on treatment and survival in laryngeal cancer. Methods: A retrospective data analysis of 412 laryngeal carcinoma patients treated at the Head and Neck Cancer Center of the University Medical Center Freiburg between 01/2010 and 12/2020 was conducted. Differences regarding TNM status, UICC classification, tumor localization, gender and age at initial diagnosis, recurrence, secondary tumors, therapy, 5-year survival, and 5-year recurrence-free survival (5YSR/5Y-RFS) were assessed for therapy initiation with or without a pretherapeutic HNT. Results: In total, 314 patients underwent a pretherapeutic HNT, and 98 received therapy initiation without an HNT. The HNT group showed significantly more advanced T stages and UICC classifications (p < 0.001; p = 0.003) and more frequent primary chemo/radiotherapy (p < 0.001). There was no significant difference regarding 5YSR (43 vs. 47 months, p = 0.96) or 5Y-RFS (48 vs. 52 months, p = 0.16). The time between initial diagnosis and therapy initiation was significantly longer when an HNT was performed (38 vs. 20 days, p = 0.008). Conclusions: The HNT group showed significantly more advanced tumor stages, suggesting that even before it became mandatory, it was frequently used for interdisciplinary case discussion in more complex cases. Due to the small number of T3/4 patients in the non-HNT group, a survival advantage of an HNT cannot be validly demonstrated in our study. However, the HNT led to broader patient counselling regarding their therapy options. At the same time, a significant delay in therapy initiation could be seen, suggesting that workflows between diagnosis, HNT presentation, and therapy initiation should be optimized.


  • Open Access

    Evaluation of cervical lymph nodes using multispectral optoacoustic tomography: a proof-of-concept study

    by Christoph Becker, Johannes Hardarson, Andrea Hoelzer, Antje Geisler, Tobias Schulz, Charlène Reichl, Neil C Burton, Tobias Schuler, Peter Kohl, Callum Zgierski-Johnston

    Objectives: Examination of lymph nodes is one of the most common indications for imaging in the head and neck region. The purpose of this study is to evaluate whether multispectral optoacoustic tomography can be used to observe chromophore differences between benign and malignant neck lymph nodes. Materials and methods: Proof-of-concept ex vivo study of resected cervical lymph nodes from 11 patients. The examination of lymph nodes included imaging with hybrid ultrasound and multispectral tomography system followed by spectral unmixing to separate signals from the endogenous chromophores water, lipid, hemoglobin and oxygenated hemoglobin; calculation of semi-quantitative parameters (total hemoglobin and relative oxygenation of hemoglobin). Comparison of the results from the hybrid measurement with the histopathological results. Results: Most patients suffered from squamous cell carcinoma (n = 7), also metastasis from salivary gland adenocarcinoma and papillary thyroid carcinoma, were included. The comparison between benign cervical lymph nodes and metastases showed significant differences for the absorbers water, lipid, hemoglobin and oxygenated hemoglobin and total hemoglobin. Conclusions: Our ex vivo study suggests that multispectral optoacoustic tomography can be used to detect differences between reactive lymph nodes and metastases. The measurement of endogenous chromophores can be used for this purpose. The examinations are non-invasively and thus potentially improve diagnostic prediction. However, potential influences from the ex vivo setting must be considered.


  • Posttherapeutische Lebensqualität nach Behandlung von Speicheldrüsenkarzinomen

    by Valentin Burkhardt, Christoph Becker

    Zusammenfassung Hintergrund Neben dem Gesamtüberleben und rezidivfreien Intervall hat sich die posttherapeutische Lebensqualität als eigenständiges Kriterium zur Therapiebeurteilung etabliert. Dabei stellen sowohl die spezifischen Veränderungen im Kopf-Hals-Bereich als auch deren Objektivierung eine besondere Herausforderung für die Erfassung der Lebensqualität dar. Verschiedene validierte Fragebögen stehen zur Verfügung. Ziel der Arbeit Anhand der Literatur wird ein Überblick über die relevanten Fragebogeninstrumente gegeben, und die spezifischen Aspekte bei Patientinnen und Patienten mit Speicheldrüsenkarzinomen werden dargestellt. Material und Methoden In einer selektiven Literaturrecherche wurden Publikationen erfasst, die sich mit der gesundheitsbezogenen Lebensqualität bei Kopf-Hals-Tumorpatienten befassen. Die Arbeiten wurden kritisch bewertet und zusammengefasst. Ergebnisse Es stehen einige validierte Fragebögen zur Messung der Lebensqualität bei Patienten mit Kopf-Hals-Tumoren sowie wenige spezifische Fragebögen für Patienten nach Parotidektomie zur Verfügung. Schlussfolgerung Durch die Erfassung der Lebensqualität mithilfe standardisierter Fragebogeninstrumente können Krankheits- und Therapiefolgen objektiviert werden. Dadurch kann auch der Bedarf supportiver Maßnahmen, z. B. zur Rehabilitation bei Fazialisparese, verlässlicher erkannt werden.


  • Open Access

    Descending necrotizing mediastinitis: etiopathogenesis, diagnosis, treatment and long-term consequences—a retrospective follow-up study

    by Thea Charlott Reuter, Valentina Korell, Jens Pfeiffer, Gerd Jürgen Ridder, Manuel Christoph Ketterer, Christoph Becker

    Purpose: The primary aim of this retrospective study was to analyze the progression of descending necrotizing mediastinitis (DNM), evaluate the impact of comorbidities on complications and mortality and to observe long-term consequences of DNM on dysphagia and measurements quality of life. DNM is a serious infectious disease that requires multimodal treatment. Current literature varies in conclusions of risk factors, management and outcome of DNM. In addition, little is known about persisting effects on quality of life. Methods: Retrospective data analysis of 88 patients with DNM representing the largest single-center study. Recording data of patients and diseases as well as clinical progression from 1997 to 2018. Two questionnaires were sent to the participants to measure quality of life and to detect dysphagia. Results: 88 patients were included. The most frequently found pathogen were Streptococcus spp. (52%). 75% of the patients underwent multiple surgeries, mean count of surgical procedures was 4.3 times. 84% received intensive care treatment. Median length of stay on the intensive care unit was 7 days. 51% had pre-existing comorbidities associated with reduced tissue oxygenation (e.g., diabetes). The most common complication was pleural effusion (45%). During the observation period, the mortality rate was 9%. 12 questionnaires could be evaluated. 67% of the participants were affected by dysphagia at the time of the survey. Conclusions: Descending necrotizing mediastinitis (DNM) is a severe disease requiring an immediate initiation of multimodal treatment. Although quality of life usually isn´t impaired permanently, dysphagia may often persist in patients after DNM.


  • Die 8. Version der TNM-Klassifikation – Fluch oder Segen für das Oropharynxkarzinom?

    by C. Becker, B. G. Hofauer, N. Mansour, M. C. Ketterer, T. Schulz, A. Knopf

    Zusammenfassung Zu Beginn des Jahres 2017 wurde die 8. Version der TNM-Klassifikation vorgestellt. Für das Oropharynxkarzinom bedeutete dies einen Paradigmenwechsel, da eine Trennung der Klassifikation in Abhängigkeit zur Assoziation mit einer Humanen-Papillomvirus-Koinfektion (HPV) hergestellt wurde. Unter Berücksichtigung der Literatur soll hier eine Übersicht über die Besonderheiten HPV-assoziierter Karzinome, die Neuerungen der TNM-Klassifikationen sowie die bestehenden Diskussionspunkte gegeben werden. Durch die Revision wurde die prognostische Aussagekraft der TNM-Klassifikation verbessert. Es bestehen jedoch weiterhin tumor- und patientenabhängige Einflussfaktoren, die bei der Erstellung von zukünftigen Versionen berücksichtigt werden müssen.


  • Open Access

    Tumor budding – prognostischer Faktor bei Speicheldrüsenkarzinomen?

    by C Becker, T Villing, T Schulz, G Kayser

    Einleitung „Tumor budding“ beschreibt das Vorliegen einzelner Tumorzellen oder –nester an der Tumorinvasionsfront. Die Tumorzellen innerhalb der Tumorbuds unterscheiden sich morphologisch von den Tumorzellen des Haupttumors. Insbesondere für Kolonkarzinome ist ist der negative Einfluss einer erhöhten Anzahl an Tumorbuds bekannt. Untersucht wird, ob das Vorliegen von Tumorbuds prognostische Aussagekraft bei Speicheldrüsenkarzinomen hat. Material / Methoden: Retrospektive Untersuchung histologischer Präparate von Patienten mit Speicheldrüsenkarzinomen (Erstdiagnose 2003-2018). Bestimmung der Tumorbuds pro mm² an digitalisierten histologischen Präparaten und Gruppierung anhand der Anzahl an Tumorbuds. Ergebnisse: Nach qualitativer Analyse des histologischen Materials konnten 105 Patienten in die Studie eingeschlossen werden. 53 der Patienten waren männlich, die häufigste Tumorentität war das Adenokarzinom (n = 23). Sämtliche UICC-Stadien waren annähernd gleichmäßig verteilt. Im Median zeigten sich 5 Tumorbuds/mm2. Patienten mit mehr Tumorbuds zeigten ein signifikant schlechteres Gesamtüberleben (p = 0,032). Ebenso zeigten sich in höheren Tumorstadien mehr Tumorbuds (p = 0,014). Eine erhöhte Anzahl an Tumorbuds war ebenso mit einer erhöhten Rate an zervikalen Lymphknotenmetastasen assoziiert (p = 0,001). Diskussion/Schlussfolgerung: Eine höhere Zahl an Tumorbuds ist mit kürzerem Gesamtüberleben, höheren Tumorstadien und häufigeren Halslymphknotenmetasen assoziiert. Die Bestimmung der Tumorbuds stellt daher ein sinnvolles Zusatzkriterium der histopathologischen Untersuchung dar, um aggressivere Tumore zu identifizieren. Poster-PDF A-1648.PDF Publication Date: 10 June 2020 (online) © . © Georg Thieme Verlag KG Stuttgart · New York

  • Open Access

    Tumor budding – prognostic factor in salivary gland carcinoma?

    by C Becker, T Villing, T Schulz, G Kayser

    Introduction Tumor budding reflects a detachment of single tumor cells or buds at the tumor invasion front. The tumor budding cells display a strikingly different architecture than the cells of the main tumor. The negative prognostic influence of an increased number of tumor buds is described for colorectal carcinoma. The aim of this study is to evaluate the prognostic value of tumor budding in salivary gland carcinoma. Methods Retrospective examination of histopathologic specimen of patients with salivary gland carcinoma (diagnosis 2003-2018). Counting of tumor buds / mm2 and classification depending on the median number of tumor buds. Results After qualitative analysis of the histopathologic specimen 105 patients were included in the study. 53 patients were male, the most common tumor entity was adeno carcinoma (n = 23). All UICC stages were distributed equally. The median number of tumor buds was 5 / mm2. Patients with a higher number of tumor buds showed a worse overall survival (p = 0.032). Higher tumor stages were associated with more tumor buds (p = 0.014). Patients with cervical lymph node metastases also showed more tumor buds (p = 0.001). Discussion A higher number of tumor buds is associated with shorter overall survival, higher tumor stage and a higher rate of cervical lymph node metastases. Tumor budding should be considered as an additional risk factor in salivary gland carcinoma to identify more aggressive tumors. Poster-PDF A-1648.PDF Publication Date: 10 June 2020 (online) © . © Georg Thieme Verlag KG Stuttgart · New York